Dr. John Winslow Alford, MD

Dr. Alford practices at Ortho RI Surgery Center (Crossings Blvd) in Warwick, Rhode Island.

Dr. Alford's NPI, 1588663587, was assigned on July 20, 2005. Dr. Alford graduated from The Warren Alpert Medical School of Brown University in 1997. Dr. Alford holds Rhode Island license MD10815.

Dr. Alford's primary practice is Ortho RI Surgery Center (Crossings Blvd), at 300 Crossings Blvd, Warwick, RI 02886. The practice phone is (716) 208-1708.

Dr. Alford's primary practice is Ortho RI Surgery Center (Crossings Blvd) in Warwick, Rhode Island. Dr. Alford is also affiliated with Kent Hospital. The medical group on file is Ortho Rhode Island. Dmand AI also links Dr. Alford to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alford practices, 6 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Alford's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Alford is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Alford's licenses on file in 2 states: Rhode Island and Illinois.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, carpal tunnel syndrome, enthesopathy in arms, hand joint or tendon inflammation, joint arthropathy and knee arthroscopy among the conditions Dr. Alford treats.

CMS data shows 641 Medicare services from Dr. Alford across 11 procedure codes in 2024, for 248 Medicare patients. Medicare paid $76,335 for them.

CMS counts 248 Medicare patients who saw Dr. Alford in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alford's median patient age at 60, with 55% women.

In 2024, Dr. Alford wrote 386 Medicare Part D claims for 304 patients. 100% of them were for generic drugs. CMS names the drug for 356 of them, across 4 drugs with 11 or more claims each, at $2,753 in total drug cost. In 2023, CMS named 432 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Alford for performance year 2024, reported as part of a group. Dr. Alford accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 109 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Alford, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Alford, published from 2016 to 2021. The most frequent topics are Bone Screws, Cell Line, Tumor and Genetic Testing. Dr. Alford has published most often in J Knee Surg. Dr. Alford's most frequent co-authors are Edward Akelman, MD, Michael Patrick Bradley, MD and Michael Louis Caravelli, MD.

CMS Open Payments shows 19 general payments to Dr. Alford from 7 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 40% of the total. Arthrex, Inc. paid the most, $973.

Dr. Alford graduated from The Warren Alpert Medical School of Brown University in 1997.

Dr. Alford is in network with 7 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.